Company Filing History:

2 out of 12,160

Bayer Aktiengesellschaft

Chemotherapeutisches Forschunginstitut Georg-speyer-haus

patents

4. 2 out of 2

Chemotherapeutisches Forschungsinstitut

patents

5. 1 out of 1

Chemotherapeutisches Forschunginstitut Georg Speyer-haus Zu Frankfurt

patent

where one patent can have more than one assignee

Years Active: 1992-2001

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6248328 - HIV-1 virus isolates of a subtype and its differential diagnostics, a vaccine against HIV-1 virus infections of this subtype and method of producing same, use of the HIV-1 virus isolates (2001-06-19),

2. 5965135 - HIV-1 virus isolates of a subtype and its differential diagnostics (1999-10-12),

3. 5861243 - Vaccine for protection against HIV infections, process for preparing (1999-01-19),

4. 5677147 - HIV-2 virus variants (1997-10-14),

5. 5637455 - HIV-2 virus variants (1997-06-10),

6. 5583035 - HIV antisense expression vectors (1996-12-10),

7. 5169842 - Oligophosphates with an antiviral action (1992-12-08),

Title: Helga Rubsamen-Waigmann: Pioneering Innovator in HIV Research

Introduction: Helga Rubsamen-Waigmann is a distinguished inventor based in Bad Soden, Germany, known for her groundbreaking contributions to HIV research. With a remarkable portfolio of seven patents, her work has significantly advanced the understanding and treatment of HIV-1 virus infections.

Latest Patents: Among her recent innovations are several significant patents that focus on HIV-1 virus isolates, notably a subtype and its differential diagnostics. These patents include the use of new HIV-1 isolates that were recovered from Indian patients, which exhibited no typical AIDS symptoms at the time of isolation. Her latest patents encompass a vaccine against HIV-1 infections and methods for their production, solidifying her role as a leader in developing solutions to combat this virus.

Career Highlights: Rubsamen-Waigmann has held influential positions in reputable companies, including Bayer Aktiengesellschaft and Qiagen GmbH. Her tenure at these organizations enabled her to refine her research and contribute to innovative solutions for HIV diagnostics and treatments.

Collaborations: During her career, she has collaborated with esteemed colleagues such as Ursula Dietrich and Hagen von Briesen. These partnerships have facilitated a richer exchange of ideas and advancements in the field of viral research, further enhancing the scope and impact of her work.

Conclusion: Helga Rubsamen-Waigmann’s dedication to HIV research and her impressive patent portfolio exemplify her commitment to innovation in the field. Her contributions not only pave the way for novel diagnostic methods and vaccines but also inspire future generations of researchers to continue the fight against HIV.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.